Articles

Combined immunodeficiency with life-threatening EBV-associated lymphoproliferative disorder in patients lacking functional CD27

CeMM Research Center for Molecular Medicine, Austrian Academy of Sciences, Vienna, Austria;
Pediatric Oncology, Hematology and Clinical Immunology, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany;
Department of Allergy and Immunology, Royal Children’s Hospital, Melbourne, Australia;
Pediatric Oncology, Hematology and Clinical Immunology, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany;
CeMM Research Center for Molecular Medicine, Austrian Academy of Sciences, Vienna, Austria;
Pediatric Oncology, Hematology and Clinical Immunology, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany;
CeMM Research Center for Molecular Medicine, Austrian Academy of Sciences, Vienna, Austria;
Medgen.at GmbH, Vienna, Austria;
Children’s Cancer Research Institute, Vienna, Austria;
Institute of Immunology, Medical University Vienna, Austria;
Department of Pediatrics and Adolescent Medicine, Division of Neonatology, Pediatric Intensive Care and Neuropediatrics, Medical University Vienna, Austria;
Pediatric Oncology, Hematology and Clinical Immunology, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany;
CeMM Research Center for Molecular Medicine, Austrian Academy of Sciences, Vienna, Austria;;Department of Pediatrics and Adolescent Medicine, Division of Neonatology, Pediatric Intensive Care and Neuropediatrics, Medical University Vienna, Austria;
Pediatric Oncology, Hematology and Clinical Immunology, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany;
St. Anna Children’s Hospital, Medical University Vienna, Austria;;Pediatric Hematology Oncology, Medical University Graz, Austria
Vol. 98 No. 3 (2013): March, 2013 https://doi.org/10.3324/haematol.2012.068791